首页> 外文期刊>American journal of medical genetics, Part A >Molecular Confirmation of HRAS p.612S in Siblings With Costello Syndrome
【24h】

Molecular Confirmation of HRAS p.612S in Siblings With Costello Syndrome

机译:Costello综合征兄弟姐妹中HRAS p.612S的分子确认

获取原文
获取原文并翻译 | 示例
           

摘要

Costello syndrome was first reported based on its characteristic phenotype. Its presentation affects multiple organ systems, including severe failure-to-thrive with macrocephaly, characteristic facial features, hypertrophic cardiomyopathy, papillomata, malignant tumors, and cognitive impairment. Heterozygous germline mutations in the proto-oncogene HRAS have been recognized to cause Costello syndrome, and its inheritance pattern would thus be autosomal dominant. Here, we report on the identification of an HRAS mutation c.34G> A, predicting a p.G12S amino acid substitution, in the surviving brother of a previously reported sibling pair, and documentation of the same change in autopsy material from his deceased sister. This represents, to our knowledge, the first molecularly confirmed Costello syndrome in siblings.
机译:首先根据其特征表型报告了Costello综合征。它的表现会影响多个器官系统,包括严重的大头畸形,特征性面部特征,肥厚型心肌病,乳头状瘤,恶性肿瘤和认知障碍。原癌基因HRAS中的杂合种系突变已被认为会引起Costello综合征,因此其遗传模式将是常染色体显性遗传。在这里,我们报道了在先前报道的同胞对的幸存兄弟中鉴定出HRAS突变c.34G> A的预测,预测到p.G12S氨基酸替换,并记录了其死者姐姐的尸检材料的相同变化。据我们所知,这是兄弟姐妹中第一个被分子证实的Costello综合征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号